Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $20,543 | 7 | 84.7% |
| Food and Beverage | $2,650 | 142 | 10.9% |
| Travel and Lodging | $961.97 | 5 | 4.0% |
| Education | $100.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $20,663 | 9 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $1,190 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $412.83 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $304.28 | 19 | $0 (2024) |
| Amgen Inc. | $288.34 | 18 | $0 (2024) |
| PFIZER INC. | $204.80 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $176.57 | 8 | $0 (2024) |
| Novo Nordisk Inc | $176.40 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $160.77 | 11 | $0 (2024) |
| SCPHARMACEUTICALS INC. | $160.20 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,661 | 38 | AngioDynamics, Inc. ($9,900) |
| 2023 | $11,613 | 52 | AngioDynamics, Inc. ($10,743) |
| 2022 | $443.84 | 28 | Merck Sharp & Dohme LLC ($99.27) |
| 2021 | $537.79 | 37 | Janssen Pharmaceuticals, Inc ($131.50) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $7,500.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $1,200.00 | General |
| Category: ET | ||||||
| 12/31/2024 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $1,200.00 | General |
| Category: ET | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | Organogenesis Inc. | APLIGRAF (Device) | Food and Beverage | In-kind items and services | $38.59 | General |
| Category: WOUND CARE | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Cardiovascular | ||||||
| 08/27/2024 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $16.06 | General |
| 08/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardiology | ||||||
| 07/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardiology | ||||||
| 06/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiology | ||||||
| 04/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiology | ||||||
| 04/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: DIABETES | ||||||
| 03/11/2024 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Travel and Lodging | In-kind items and services | $147.39 | General |
| Category: Vascular/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 252 | 411 | $890,064 | $113,762 |
| 2022 | 6 | 273 | 407 | $1.1M | $151,248 |
| 2021 | 4 | 266 | 394 | $99,156 | $23,583 |
| 2020 | 6 | 483 | 538 | $124,909 | $26,759 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance | Office | 2023 | 70 | 147 | $735,000 | $89,749 | 12.2% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 16 | 16 | $96,000 | $10,878 | 11.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 137 | $41,785 | $9,855 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $7,020 | $1,551 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 23 | $4,784 | $1,157 | 24.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 73 | $5,475 | $571.89 | 10.4% |
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance | Office | 2022 | 85 | 168 | $840,000 | $110,454 | 13.1% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2022 | 37 | 40 | $240,000 | $29,014 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 108 | $32,940 | $8,377 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $6,552 | $1,524 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 26 | $5,408 | $1,445 | 26.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 51 | $3,825 | $433.74 | 11.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 210 | $64,050 | $16,690 | 26.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $18,720 | $3,819 | 20.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 42 | $8,736 | $2,179 | 24.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 85 | 102 | $7,650 | $895.56 | 11.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 251 | 296 | $90,280 | $20,036 | 22.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $15,444 | $3,289 | 21.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 45 | $9,360 | $1,863 | 19.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 117 | 119 | $8,925 | $1,294 | 14.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 12 | 14 | $280.00 | $184.22 | 65.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 28 | 31 | $620.00 | $92.10 | 14.9% |
About Kimalisa Locklear
Kimalisa Locklear is a Nurse Practitioner healthcare provider based in Fayetteville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1306482500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimalisa Locklear has received a total of $24,256 in payments from pharmaceutical and medical device companies, with $11,661 received in 2024. These payments were reported across 155 transactions from 25 companies. The most common payment nature is "Long term medical supply or device loan" ($20,543).
As a Medicare-enrolled provider, Locklear has provided services to 1,274 Medicare beneficiaries, totaling 1,750 services with total Medicare billing of $315,351. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Fayetteville, NC
- Active Since 11/22/2019
- Last Updated 11/22/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1306482500
Products in Payments
- Auryon Laser System 100-120 Vac (Device) $15,020
- VenaCure 1470 Pro (Device) $5,643
- Venclose Maven Catheter (Device) $1,190
- XARELTO (Drug) $412.83
- VERQUVO (Drug) $304.28
- Repatha (Biological) $288.34
- ELIQUIS (Drug) $236.43
- JARDIANCE (Drug) $176.57
- FUROSCIX (Drug) $160.20
- ENTRESTO (Drug) $86.06
- LEQVIO (Drug) $74.71
- Kerendia (Drug) $60.87
- BRILINTA (Drug) $46.45
- Arcalyst (Drug) $42.87
- FARXIGA (Drug) $39.17
- APLIGRAF (Device) $38.59
- Ozempic (Drug) $34.87
- Inpefa (Drug) $33.22
- OPSUMIT (Drug) $25.54
- General - Therapies (Device) $24.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Fayetteville
Pedro Figueiredo Ferreira
Nurse Practitioner — Payments: $22,348
Marlys Bitner, Aprn, APRN
Nurse Practitioner — Payments: $7,325
Elizabeth Burns, Aprn, APRN
Nurse Practitioner — Payments: $6,491
Mrs. Jennifer Reid, Dnp, Agnp-C, DNP, AGNP-C
Nurse Practitioner — Payments: $5,671
Taylor Marshall, Apn, APN
Nurse Practitioner — Payments: $5,072
Shannon Snyder, Fnp, FNP
Nurse Practitioner — Payments: $4,371